Cargando…

Inflammation Markers and Metabolic Characteristics of Subjects With 1-h Plasma Glucose Levels

OBJECTIVE: To assess the association of 1-h plasma glucose (1hPG) and inflammation with normal glucose tolerance (NGT) and pre-diabetes. RESEARCH DESIGN AND METHODS: A cohort of 1,062 subjects was enrolled. After oral glucose load (oral glucose tolerance test), we compared subjects with NGT and pre-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bardini, Gianluca, Dicembrini, Ilaria, Cresci, Barbara, Rotella, Carlo Maria
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809294/ https://www.ncbi.nlm.nih.gov/pubmed/19918010 http://dx.doi.org/10.2337/dc09-1342

Ejemplares similares

Association Between Oral Isotretinoin Therapy and Unmasked Latent Immuno-Mediated Diabetes
por: Dicembrini, Ilaria, et al.
Publicado: (2009)

Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study
por: Pala, Laura, et al.
Publicado: (2012)

From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy
por: Dicembrini, Ilaria, et al.
Publicado: (2011)

Bone: Incretin Hormones Perceiver or Receiver?
por: Dicembrini, Ilaria, et al.
Publicado: (2012)

The therapy of insulin resistance in other diseases besides type 2 diabetes
por: Pala, Laura, et al.
Publicado: (2014)

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
por: Monami, Matteo, et al.
Publicado: (2012)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)
por: Bardini, Gianluca, et al.
Publicado: (2010)

Metabolic profile of normal glucose-tolerant subjects with elevated 1-h plasma glucose values
por: Pramodkumar, Thyparambil Aravindakshan, et al.
Publicado: (2016)

Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
por: Mannucci, Edoardo, et al.
Publicado: (2013)

Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)
por: Dicembrini, Ilaria, et al.
Publicado: (2022)

Cardiometabolic importance of 1-h plasma glucose in obese subjects
por: Haverals, Lien, et al.
Publicado: (2019)

Association of pulse pressure with fasting and 2-h plasma glucose in subjects with different degrees of glucose tolerance
por: Silva, Letícia Maria Tedesco, et al.
Publicado: (2015)

False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change
por: Cresci, Barbara, et al.
Publicado: (2014)

Cigarette Smoking as a Predictor of Sodium–Glucose Cotransporter 2 Inhibitor–Associated Genital Infections: A Retrospective Cohort Study
por: Scoccimarro, Daniele, et al.
Publicado: (2021)

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Mannucci, Edoardo, et al.
Publicado: (2010)

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Monami, Matteo, et al.
Publicado: (2011)

Fasting plasma glucose levels and coronary artery calcification in subjects with impaired fasting glucose
por: Eun, Young-Mi, et al.
Publicado: (2016)

Characteristics of Glucose Metabolism in Nordic and South Asian Subjects with Type 2 Diabetes
por: Wium, Cecilie, et al.
Publicado: (2013)

Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies
por: Silverii, Giovanni Antonio, et al.
Publicado: (2021)

Effectiveness of low‐carbohydrate diets for long‐term weight loss in obese individuals: A meta‐analysis of randomized controlled trials
por: Silverii, Giovanni Antonio, et al.
Publicado: (2022)

Plasma Metabolic Signatures of Healthy Overweight Subjects Challenged With an Oral Glucose Tolerance Test
por: Fiamoncini, Jarlei, et al.
Publicado: (2022)

Correction to: Glucose control in diabetes during home confinement for the first pandemic wave of COVID‑19: a meta‑analysis of observational studies
por: Silverii, Giovanni Antonio, et al.
Publicado: (2021)

The association between plasma zinc concentrations and markers of glucose metabolism in adults in Cameroon
por: Mba, Camille M., et al.
Publicado: (2023)

Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support
por: Scoccimarro, Daniele, et al.
Publicado: (2021)

The Monitoring of Protein Markers of Inflammation and Serum Lipid Concentration in Obese Subjects with Metabolic Syndrome
por: Sladoje, Dragana Puhalo, et al.
Publicado: (2017)

Meaning of upper limit of normal range of post‐load 1‐h plasma glucose level defined by oral glucose tolerance test in Japanese subjects
por: Iwao, Tadashi, et al.
Publicado: (2013)

Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project
por: Dicembrini, Ilaria, et al.
Publicado: (2021)

Cardiovascular Characteristics in Subjects With Increasing Levels of Abnormal Glucose Regulation: The Strong Heart Study
por: Capaldo, Brunella, et al.
Publicado: (2013)

Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels
por: Lin, Chun-Chung, et al.
Publicado: (2019)

Association of Plasma Levels of Resistin with Subcutaneous Fat Mass and Markers of Inflammation but not with Metabolic Determinants or Insulin Resistance
por: Won, Jong Chul, et al.
Publicado: (2009)

Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test
por: Zywicki, Viola, et al.
Publicado: (2022)

Fit and Motivated: Outcome Predictors in Patients Starting a Program for Lifestyle Change
por: Cresci, Barbara, et al.
Publicado: (2013)

Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance
por: Shannon, Chris, et al.
Publicado: (2018)

Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2010)

Cardiovascular effects of basal insulins
por: Mannucci, Edoardo, et al.
Publicado: (2015)

Plasma Levels of Neudesin and Glucose Metabolism in Obese and Overweight Children
por: Vergani, Edoardo, et al.
Publicado: (2022)

One-Hour Post-Load Plasma Glucose Levels are Associated with Early Arterial Stiffness in Subjects with Different Glucose Tolerance
por: Wang, Rui, et al.
Publicado: (2022)

Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers
por: Nyström, Niklas, et al.
Publicado: (2022)

Maternal plasma metabolic markers of neonatal adiposity and associated maternal characteristics: The GUSTO study
por: Chia, Ai-Ru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8g9n72oi5kfcach5h4179ihk7r